Stay updated on Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The BrUOG 354 clinical trial record is displayed with its study details, eligibility criteria, locations, outcomes, and record history.
    Difference
    55%
    Check dated 2026-11-09T14:55:58.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0. The study record area still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:25:48.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added announcing updates and FAQs about terminology changes during the agency transition.
    Difference
    1%
    Check dated 2026-10-26T16:45:23.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision number was updated from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T21:51:40.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site revision label in the page footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T04:31:29.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page, signaling a new revision of the study record. This update appears to be a maintenance/version update rather than a change to study details or results.
    Difference
    19%
    Check dated 2026-09-21T22:51:22.000Z thumbnail image

Stay in the know with updates to Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab±Ipilimumab in Ovarian & Clear Cell Carcinomas Clinical Trial page.